Houston, TX, United States of America

Jun Wei

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Texas System. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Wei. Retrieved from https://idiyas.com/inventor/jun-wei-oi1o0f41

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Jun Wei

Introduction

Jun Wei is a prominent inventor based in Houston, TX (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of miRNA technologies. His work focuses on enhancing immune responses against cancer, which has the potential to improve therapeutic outcomes for patients.

Latest Patents

Jun Wei holds a patent for "miRNA for treating cancer and for use with adoptive immunotherapies." This patent outlines the use of specific miRNAs, such as miR-124, miR-142, and miR-138, to promote immune destruction of cancer cells or reduce immune suppression in affected individuals. The application of these miRNAs in combination with adoptive immunotherapy represents a promising advancement in cancer treatment strategies.

Career Highlights

Jun Wei is affiliated with The University of Texas System, where he conducts his research. His work has garnered attention for its innovative approach to cancer therapy, and he continues to explore new avenues for enhancing patient care through scientific discovery.

Collaborations

Jun Wei collaborates with Amy Heimberger, a fellow researcher in the field. Their partnership aims to further the understanding and application of miRNA technologies in cancer treatment.

Conclusion

Jun Wei's contributions to cancer treatment through his innovative use of miRNA highlight the potential for advancements in immunotherapy. His work not only showcases the importance of research in this area but also emphasizes the collaborative efforts that drive scientific progress.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…